Benzinga - by Surbhi Jain, .
In the fast-evolving landscape of generative artificial intelligence (GenAI), mega-cap technology giants are engaged in fierce competition. According to a Raymond James Financial Inc (NYSE:RJF) analyst, a few key names will win the race toward commercialization.
GenAI Is Still In Its Early Stages
As reported by CNBC, analyst Josh Beck, in a December note, expressed optimism about the potential of GenAI. Beck stated that despite market enthusiasm, the technology is still in its early stages.Beck envisions GenAI evolving into an embedded operating system (OS). It could span across consumer and business platforms, and serve as an intelligent agent or copilot for a myriad of tasks (i.e., drafting business contracts).
Also Read: EXCLUSIVE: Marc Chaikin Bullish On AI-Enhanced Software Companies, Forecasts S&P 500 Rally To Continue Into 2024
The adoption of generative AI is scaling at an impressive rate, approximately 40X faster than other major tech platforms. Venture capitalists have poured around $40 billion into generative AI startups, indicating strong investor confidence in the technology’s future.
Key GenAI Stocks To Consider For 2024
Raymond James highlighted key stocks that are already exerting outsized influence in the GenAI space:Now Read: AI ‘Unlikely’ To Replace Financial Advisors Due To ‘Fiduciary’ Issue
Image: Shutterstock
© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.